2006

Cardiac Arrhythmias 2005

Proceedings of the 9th International Workshop on Cardiac Arrhythmias (Venice, 2–5 October 2005)

Editors:

ISBN: 978-88-470-0370-5 (Print) 978-88-470-0371-2 (Online)

Table of contents (87 chapters)

previous Page of 5
  1. Supraventricular Arrhythmia and Atrial Flutter

    1. Front Matter

      Pages 1-1

    2. No Access

      Book Chapter

      Pages 3-12

      Right and Left Atrial Flutter: How To Differentiate Them on the Basis of Surface Electrocardiogram?

    3. No Access

      Book Chapter

      Pages 13-19

      Atypical Atrial Flutter: How to Diagnose, Locate, and Ablate It

    4. No Access

      Book Chapter

      Pages 21-31

      Catheter Ablation of Typical Atrial Flutter. What Are the Long-Term Results and Predictors of Recurrences?

    5. No Access

      Book Chapter

      Pages 33-38

      Atrial Fibrillation After Ablation of Atrial Flutter: Who Is at Risk?

    6. No Access

      Book Chapter

      Pages 39-54

      Electroanatomic Mapping to Support Ablation of Complex Supraventricular Arrhythmias: Does It Matter?

  2. Atrial Fibrillation: Pathophysiology, Clinical and Therapeutic Aspects

    1. Front Matter

      Pages 55-55

    2. No Access

      Book Chapter

      Pages 57-60

      Idiopathic Atrial Fibrillation: Which Electrophysiological Substrate?

    3. No Access

      Book Chapter

      Pages 61-66

      Inflammation and Infection: Underestimated Causes of Atrial Fibrillation?

    4. No Access

      Book Chapter

      Pages 67-73

      Atrial Remodelling: What Have We Learned in the Last Decade?

    5. No Access

      Book Chapter

      Pages 75-82

      Atrial Fibrillation and Heart Failure: Does One Epidemic Feed the Other?

    6. No Access

      Book Chapter

      Pages 83-88

      Atrial Fibrillation: What Is the Impact of the Different Therapies on Quality of Life?

    7. No Access

      Book Chapter

      Pages 89-94

      ‘Pill-In-The-Pocket’ Approach for Outpatient Treatment of Recent Onset Atrial Fibrillation: The Obvious Solution?

    8. No Access

      Book Chapter

      Pages 95-100

      Pharmacological Cardioversion of Atrial Fibrillation: Which Drugs Are Preferred, Class IC or Class III?

    9. No Access

      Book Chapter

      Pages 101-107

      Early Recurrences of Atrial Fibrillation: How To Predict Them?

    10. No Access

      Book Chapter

      Pages 109-115

      Dronedarone for Prevention of Atrial Fibrillation: An Unfulfilled Promise?

    11. No Access

      Book Chapter

      Pages 117-120

      Prognosis and Management of Atrial Fibrillation in Patients Without Structural Heart Disease

    12. No Access

      Book Chapter

      Pages 121-126

      Primary Prevention of Atrial Fibrillation in Hypertensive Patients: What Is New from the LIFE Trial?

    13. No Access

      Book Chapter

      Pages 127-130

      Prognosis and Management of Atrial Fibrillation in Different Clinical Settings: Acute Myocardial Infarction

    14. No Access

      Book Chapter

      Pages 131-136

      Post-CABG Atrial Fibrillation: What Are the Incidence, Predictors, Treatment, and Long-Term Outcome?

    15. No Access

      Book Chapter

      Pages 137-143

      Post-PCI Atrial Fibrillation: Possible Clinical and Prognostic Significance

    16. No Access

      Book Chapter

      Pages 145-150

      Perioperative Interruption of Warfarin: How Effective and Safe Is Bridging Therapy with Low-Molecular-Weight Heparin?

previous Page of 5